By Vaccinationist - PubChem, WikipediaIntra-CellularJohnson & Johnson acquires Intra-Cell...Johnson & Johnson has announced the acquisition of biopharmaceutical company Intra-Cellular Therapies, strengthening its position in the market for central nervous system disorder treatments. The $14.6 … more ➔
robin_24, WikipediaLeyden LabsLeyden Labs secures $70M to advance intran...Leyden Labs has raised $70 million in a funding round led by ClavystBio and Polaris Partners, boosting its efforts to develop intranasal antibody therapies targeting respiratory viruses, including influenza … more ➔
Clinical trialsFirst in vivo CAR gene therapy trial in Eu...The Paul Ehrlich Institute (PEI) has approved expansion of the global INVISE Phase 1 clinical trial to Europe. The study aims to evaluate first-in-class gene therapy for the treatment of B-cell mali … more ➔
Image by Pete Linforth from Pixabay.Angelini VenturesAngelini Ventures co-leads €20m Series A...Angelini Ventures, the corporate venture capital arm of Angelini Industries, focused on investing in early-stage companies in BioTech and Digital Health, co-leads €20m Series A funding round in Neumirna … more ➔
Justlight, AdobeStockArgobioNew RNA company Inverna Therapeutics launc...Inverna Therapeutics, a Danish biotech company, has officially launched to develop innovative RNA-based therapies targeting severe genetic diseases. Co-founded by the University of Southern Denmark and … more ➔
Jeyaratnam Caniceus/Pixabay.comForbionUSD410m Mega Series A for yet another GLP-...Verdiva Bio, a London-based biotech, has raised an extraordinary US$410m in its oversubscribed Series A round, making it potentially the largest Series A ever raised by a U.K.-based biotech company, … more ➔
XyloCor TherapeuticsGene TherapyJeito Capital leads $67.5m Series B financ...A US$67.5m Series B financing in XyloCor Therapeutics led by French Jeito Capital will fund two double-blind Phase 2 trials for XC001, a pioneering gene therapy for severe cardiovascular disease. more ➔
123rf.com/valentinakruGenomic EnglandQiagen joins Newborn genomic screening of...The aim of this unique initiative, part of the so-called Generation Study, is to sequence the genomes of 100,000 newborns in England to enable the early detection of over 200 selected conditions and … more ➔
IPS-Integrated Project Services, LLC / WuXi BiologicsWuXiWuXi Biologics Sells Irish Vaccine Site to...WuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global … more ➔
Orbis MedicinesOrbisOrbis Medicines secures €90m to advance...Orbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning. more ➔
By Vaccinationist - PubChem, Wikipedia
robin_24, Wikipedia
Image by Pete Linforth from Pixabay.
Justlight, AdobeStock
Jeyaratnam Caniceus/Pixabay.com
XyloCor Therapeutics
123rf.com/valentinakru
IPS-Integrated Project Services, LLC / WuXi Biologics
Orbis Medicines